Concepedia

Author

E. Jenny Heathcote

Also Known As

E HEATHCOTE, E Heathcote, E J Heathcote, E Jenny Heathcote, E Jenny L. Heathcote, E. Heathcote, E. J. HEATHCOTE, E. J. Heathcote, E. J. L. Heathcote, E. Jenny Heathcote

103

Publications

11.9K

Citations

36

H-Index

54

Concepts

All Affiliations

EJ

About

E. Jenny Heathcote is an author at University of Toronto specializing in medicine, hepatology, and hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

20

3.2K

2

Health Sciences

2

2

77

3

Social Sciences

1

1

45

4

Epidemiology

1

1

45

5

Gastroenterology

1

1

642

E. Jenny Heathcote

×

45

Publications

10.2K

Citations

31

H-Index

YearCitations

2008

1.2K

2003

996

2000

885

2006

882

2007

773

2003

766

1997

642

2007

600

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).

Marion G. Peters, Hie‐Won Hann, Paul Martin,

Gastroenterology

2003

553

2005

535

Page 1